STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #405 by analyst upside · 2026-06-27
MRMD
MariMed Inc.
Healthcare · Market Cap $29M · P/E 0x
ANALYST PRICE TARGET
+242.5%
implied upside to consensus target
Current Price $0.07
Consensus Target $0.25
Bull Target $0.25
Bear Target $0.25
Analysts Covering 1
ANALYST CONSENSUS — BUY
Strong Buy
0
Buy
1
Hold
0
Sell
0
52-Week Low $0.06
52-Week High $0.23
YTD Return -22.2%
FUNDAMENTALS
Market Cap $29M
P/E Ratio (TTM) N/A
Forward P/E -2.4x
EPS (TTM) $-0.04
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $161M
Profit Margin -7.9%
52-WEEK RANGE
52-Week Low $0.06
52-Week High $0.23
Current Price $0.07
Bear Target $0.25
Bull Target $0.25
● Now $0.07 ● Target $0.25
TRADING DATA
Avg Volume 749K
YTD Return -22.2%
Analyst Count 1
Consensus Buy
Upside to Target +242.5%
Last Updated 2026-06-27

ANALYST SUMMARY

MariMed Inc. (MRMD) is currently trading at $0.07 with a Wall Street consensus price target of $0.25, implying potential upside of 242.5% over the next 12 months. 1 analysts currently cover MRMD, with a consensus rating of Buy — 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $0.25, while the most cautious has a target of $0.25.

MRMD operates in the Healthcare sector with a market capitalisation of $29M. The stock is down 22.2% year-to-date and is currently trading near the lower end of its 52-week range of $0.06 – $0.23.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
40
out of 100
Coverage depth
5/30
Consensus clarity
8/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →